Purpose: The present study analyzed 53 consecutive patients with oral squamous cell carcinoma (OSCC) over a period of 6 years (from 2006 to 2012) to determine if epidemiological differences correspond to different stages of the disease and affected the survival rate. Methods: In this cohort study, medical records were reviewed retrospectively. The epidemiological data included age, gender, residence, tobacco habit, duration of tobacco use, blood group, and hemoglobin. The clinicopathological features noted were tumor site, tumor size, nodal status, histopathological grade, metastasis, clinical grade, and treatment. We analyzed the relationship of epidemiological characteristics with treatment by the Chi-square test and survival analysis using the Kaplan-Meier curve. The statistical test significance level was set at P < 0.05. Results: Of the 53 patients of OSCC confirmed through histopathological diagnosis, the ratio of female to male was 1.65:1 and mean age was 51.83 ± 12.57 years. Majority of the cases, i.e., 43 (81.13%) were from rural area. 51 (96.22%) patients were tobacco habituates, of which 41 (80.40%) were smokeless tobacco chewers. Buccal mucosa was the most common tumor site, i.e., 23 (43.40%). The clinical presentation of ulcer/ ulceroproliferative cases, i.e., 43 (81.13%) was most frequent. Moreover, statistical significance was observed with univariate association analysis between clinical presentation and treatment; in patients who underwent surgical treatment (P = 0.04). Of 35 (66.04%) patients who underwent surgical treatment, only 7 (20%) patients had recurrence. Survival rate was 90.57% at 3-year follow-up.
Introduction
Oral and pharyngeal cancers are common and identified as significant public health threats worldwide; their incidence and mortality vary by region. Oral squamous cell carcinoma (OSCC) is the most common subtype. It is considered that early detection and treatment can prevent oral cancer, however a maximum of the OSCC cases are diagnosed at late phase (Stage III or Stage IV) which affect the chances of survival. [1] The management of OSCC varies considerably, but the standard procedure remains local excision, with or without neck dissection, followed by radiotherapy (RT) depending on the risk factors. Supplemental chemotherapy (CT) is occasionally used to improve locoregional and distant control. [2] In spite of all these, the survival rate is only 53%. [3] Oral cancer holds the eighth position in the cancer incidence ranking worldwide, with epidemiologic variations between different geographic regions (it is the third most common malignancy in South-Central Asia). [4] Tobacco (smoking and smokeless habits) and alcohol consumption are the most commonly cited etiological agents and risk factors. [5] The aim of this hospital-based study was a retrospective investigation of OSCC cases for sociodemographic, etiology, stage of diagnosis, treatment provided, and descriptive analysis of various factors which affect the survival of these patients.
Methods

Data collection
The study comprised a retrospective analysis of patients with primary cancer of oral cavity diagnosed at MS Ramaiah Hospitals and Faculty of Dental Sciences, MSRUAS, during 2006-2012. The study included medical records of 53 patients diagnosed with a primary invasive tumor of the oral cavity (International Classification of Diseases [ICD] codes C01-C06). [6] All the patients diagnosed with oral cancer were identified from the patient admission register in the Department of Oral and Maxillofacial Surgery, and a data collection form was designed. The detailed information was then entered in these data collection forms from the inpatient files in the records department of the hospital. Data collection forms and the record files were then cross-checked to ensure inclusion of all the parameters to be studied. Records from the patients who underwent biopsy alone (without treatment) and incomplete records were excluded from the study.
The information abstracted from patient records included age, gender, and the geographical location of the stay. The tumor, node, metastases (TNM) stage, primary tumor site, and histopathological grade of cancer were retrieved from histopathological reports. Methods of treatment (resection, preoperative or postoperative RT) and the final dates of admission to the hospital were also recorded along with the date of discharge.
The cancer cases were coded according to the ICD-10. [6] The clinical staging of cancer was based on the fourth edition of the TNM system and involved a composite of clinical parameter quantification, with the components being the size of the primary tumor (T stage), the presence or absence of the regional lymph node involvement (N stage), and the presence or absence of distant metastasis (M stage). Pathological TNM was available for patients who were treated surgically. The histopathological diagnosis and the report of mild, moderate, and poorly differentiated squamous cell carcinomas (SCC) were graded according to the WHO guidelines. All the data were primarily recorded in cross-tabulations, and descriptive analysis was done to demonstrate associations between sociodemographics and tumor characteristics. Percentages of cases receiving primary, single, and combination therapy were analyzed.
Statistical analysis
Clinical and demographic characteristics of the variables are summarized as number (%) for categorical variables and mean±standard deviations for continuous variables. Statistical analysis included evaluation of OSCC data by the Chi-square test. Kaplan--Meier curve of OSCC patients was presented for the cumulative survival rates versus follow-up time. All statistical calculations were two tailed with 95% confidence interval. The level of statistical significance was set at P<0.05. Statistical analysis was performed using Medcalcv16.4.3. [7] 
Results
Sociodemographic data
In the period studied, a total of 53 patients diagnosed with oral cancer based on histopathology, satisfying the inclusion and exclusion criteria, were included in the study. Out of these 53 patients, 20 (37.74%) were male and 33 (62.26%) were female. The age of patients ranged between 26 to 80 years with a mean age of 51.83 ± 12.57 years. No statistical difference was found in gender versus age analysis (P = 0.2708) [ Table 1 ].
2 of the 53 patients were with no habits while the rest 51 (96.22%) patients were tobacco habituates, and the consumption ranged from 6 to 50 years, the mean duration being 19.40 ± 11.50 years. The difference in tobacco habit between males and females was found to be statistically significant (P = 0.0001). In particular, out of the 51 tobacco habituates, 10 (19.60%) males were smokers while remaining 41 were smokeless tobacco chewers, of which males constituted 9 (17.64%) and females 32 (62.74%). Although smokeless tobacco was the most noted habit among our patients, there was no statistical significance found between the habit and the side of occurrence (P = 0.0835) [ Table 2 ].
O+ve blood group was observed in 22 (41.51%) cases, AB in 15 (28.30%), B in 9 (16.98%), and A in 7 (13.21) cases [ Table 2 ].
Tumor characteristics [Table 2]
The site of occurrence of tumor was buccal mucosa in 23 (43.40%) patients, alveolus in 11 (20.75%), gingivobuccal sulcus (GBS), tongue, and retromolar trigone (RMT) in 4 (7.55%) patients each, palate in 1 patient (1.89%), and combination in 6 patients (11.32%). The most common clinical presentation was ulcer/ulceroproliferative 43 (81.13%) followed by exophytic in 9 (16.98%) patients. Bone erosion was less frequent in 18 cases (33.96%).
Majority of the patients presented for treatment in the late stages, i.e., 46 (86.79%). According to clinical TNM classification, the current study revealed that 22 (41.51%) cases were T4, 13 (24.53%) were T2, and 9 (16.98%) were of T1 and T3. Of the 53 cases, in 15 cases, there was no lymph node metastasis whereas N1 was examined in 22 (41.51%) patients, N2a in 2 (3.77%), N2b in 10 (18.87%), and N2c in 4 (7.55%) patients. Of the 32 patients who underwent surgical resection with neck dissection, 10 were positive for lymph node metastasis.
Univariate analysis of the association between treatment and clinical presentation showed significantly higher number of OSCC cases with ulcer/ulceroproliferative clinical representation who underwent surgery (P = 0.0335). However, other comparisons of treatment versus TNM classification (P = 0.1574), N-stage (P = 0.1355), lesion site (P = 0.102188), biopsy (P = 0.2698), clinical staging (P = 0.082), age (P = 0.3843), gender (P = 0.2782), residence (P = 0.167), and tobacco habit (0.2526) were not statistically significant. In histopathological analysis, we observed 21 cases of welldifferentiated tumor and 32 cases of moderately differentiated SCC. The majority (66.03%) of the cases were treated with curative intent. Palliative treatment was given to 33.9% of patients. Definitive treatment included single modality treatment such as surgery (wide local excision with neck dissection), RT or CT, or a combination of treatment modalities such as surgery and RT, RT, and CT. The most frequently employed strategy was surgery alone in 29 (54.72%), followed by RT alone in 12 (22.64%), and RT with CT in 6 (11.32%) patients. Only a small percentage of patients received postoperative RT 5 (9.43%) or combined RT and CT with surgery 1 (1.89%).
Among the 35 patients who underwent surgery, only in one patient, neck was not addressed, five patients underwent supraomohyoid neck dissection and the rest 29 had modified radical neck dissection. Primary closure was done for 6 patients, and the remaining 29 had reconstruction done using either tongue flap or pectoralis major myocutaneous flap.
The average preoperative hemoglobin was 12.1, being as low as 5.6 and as high as 17.6 [ Table 2 ]. Only 12 patients out of 35 who underwent surgery required blood component transfusion. The post-operative average length of hospital stay was 28.8 days ranging from 6 to 66 days. The post-operative feeding in all but 20 patients was managed with nasogastric tubes, the average duration of Ryles tube feeding was 14.63 days ranging from a min of 6 days to a maximum of 38 days. The Kaplan-Meier survival probability estimate at 36 months was 0.90 [ Figure 1 ].
Discussion
The oral cavity in spite of being completely accessible to thorough examination, oral cancer is a global health problem. In India, oral cancer constitutes the largest group of malignancies with incidence rates of 30-40%, posing a significant challenge to health-care services. It is the most common cancer in males and 3 rd most common in females in India. [8] Neoplasms of diverse cellular origin arise in the oral cavity, and among this, OSCC arising from the mucosa of the oral cavity constitutes to over 90%. Oral cancer encompasses all the malignancies originating in the oral tissues, including cancers of the lip, tongue, and gingiva, floor of the mouth, buccal mucosa, palate, and the retro-molar trigone.
This study represents a retrospective review of a patient cohort of all cases of oral cancer recorded at MS Ramaiah Hospitals from January 2006 to December 2012.
The characteristics of oral cancer patients in this study do not have a typical pattern, being common in older age group >50 years and higher among males, although it was commonly associated with risk habits as described in the literature. The incidence of oral cancer increases with age, predominantly in people aged 50 years and above which is generally attributed to indiscriminate substance abuse, particularly the use of tobaccorelated products over a considerable period of time. [9] Some studies define young people as aged 45 years and below. [10] Nearly 28.3% of patients were of age younger than 45 years and 43% below age 50 years in our study which is comparable to a study in the UAE. [10] Most studies have reported a mean age of more than 60 years. Recent Indian studies have shown an increased incidence of oral cancer in younger age group with a mean age of 51 years, [11] as was seen in the present study, the mean age is 52 years and the age of the patients was between 41 to 50 years. This difference in the mean ages for the occurrence of oral cancers can either be because of early diagnosis resulting from increased awareness or the increased reach of the healthcare facilities and a higher rate of consumption of the smokeless tobacco in the Indian subcontinent. A greater percentage of younger patients indicate that we should emphasize more on the hazard of smokeless tobacco in youth and also be vigilant to biopsy any suspicious lesion at the first examination.
A clear female predominance was seen with a male-to-female ratio of 0.61 in contrast to the ratio of 2.1:1 reported by Lam et al. [5] and Aruna et al. [11] whereas an even higher ratio of 4.8:1 was reported by Gervásio et al. [12] Such contrasting high prevalence in women in this study can be related to the inconspicuous use of smokeless tobacco and also the greater social acceptance of smokeless tobacco in the community. It can also be attributed to the fact that women start chewing 2 years earlier and also have greater susceptibility to oral damage by tobacco as reported by Balaram. [13] As most of our patients belonged to the rural population, they sought treatment at very late stages; more late presentation is common in the female population who many times do not report at all until it is very late. [11] Another study by Honorato et al. reported that tobacco use and metastasis were independent prognostic factors in males while the anatomical site and metastasis were independent factors in females. [14] In light of the mentioned studies and our opinion, we believe that smokeless tobacco has a varying effect on males and females.
The majority of patients, i.e., 30 (56.60%) presented in Stage IV, 16 (30.19%) presented in Stage III, and only 3 (5.66%) and 4 (7.55%) presented in Stages II and I, respectively. These high numbers of the advanced stage presentation can be attributed to the delay in diagnosis which can be either due to delay in seeking medical advice because of poverty, illiteracy, and availability of alternative medicine or due to professional delay. [15] Nearly 96.22% of patients had one or the other risk habit, and only 3.78% of patients had none, this value is higher than the one reported by Sankaranarayanan et al., 1990 , [16] probably because of the early age of commencement of tobacco consumption. The duration of consumption of tobacco ranged from 6 to 50 years in the present study.
The most commonly affected anatomic site was buccal mucosa, [8] i.e., 23 (43.40%) followed by alveolus 11 (20.75%) and GBS, tongue, and RMT 4 (7.55%) each, which is consistent with the study by Aruna et al., [11] Mehrothra et al., [8] and Pathak et al. [17] On the other hand, an independent study by Shenoi et al. and Anis et al. [10] showed tongue to be the most commonly affected site. [18] The higher incidence of buccal mucosa carcinoma is due to the greater number of patients using smokeless form of tobacco which is kept as a quid in the buccal pouch.
The common clinical presentation was ulcerative lesion among 43 (81.13%) patients, followed by proliferative and exophytic growth in 9 (16.98%). This is in contrast to the study by Anis et al. [10] where only 31.7% of patients presented with an ulcer, this difference in our opinion might be due to a greater percentage of patients using smokeless tobacco and its placement in the buccal mucosa. 1 (2%) of the 53 patients in our study presented with SCC in leukoplakia which is similar to the rate in the English literature, i.e., 3-33%. [10] The majority of tumors in the study were moderately differentiated, i.e., 60.38% followed by 39.62% which were well differentiated. Moderately differentiated carcinoma was the most common finding in studies conducted in Pakistan [10] and Davangere (India), [19] whereas in Iran, Libya, [10] and Allahabad (India), [8] well-differentiated SCCs were more common. These findings suggest that both moderately differentiated and welldifferentiated carcinomas were most common with slight variations in different studies and ages.
46 of 53 patients presented with a clinically advanced disease (Stage III and IV) whereas only 7 were early stage. Although the literature suggests multimodality treatment to be more effective than a single modality for the treatment of advanced cancers, [5] 29 (54.71%) patients in the present study received a single modality, i.e., surgery, followed by only 6 (11.32%) patients treated with combined surgery and RT. Post-operative RT was considered for those patients with positive surgical margins or positive lymph node metastasis. If surgical margins were clear and lymph nodes were negative, RT was not given, even when tumor size was T4.
32 of 53 patients in the present study underwent neck dissection, of which 10 were positive for lymph node metastasis. The detection of lymph node involvement in the absence of clinical and radiological evidence is defined as occult metastasis or micro metastasis. In approximately 30% of the patients with early carcinoma, occult metastasis has been noted. [10] None of the cases in the present study had occult metastasis. The percentage of positive neck node was 31.25% which is similar to the rates reported in literature, i.e., 32-34%. [10] As pointed out earlier by McAuley et al., [20] the length of hospital stay is greatly affected by the duration of postoperative nasogastric tube feeding, without any consequences on the healing and orocutaneous fistula formation in patients undergoing oral cancer resection and flap reconstruction. Patients in their study started oral feeds on or before the 6 th day. The average length of hospital stay was reduced to 11 days compared to the 28.8 days in the present study where our patients started oral diet not before 15 days after surgery. All the 33 patients in this study under tube feeding had undergone local flap reconstruction as compared to their study where the patients had free flap reconstruction.
The survival rate of our patients was 90.57% at 3-year followup. This high rate of success could be attributed to surgery being a chief modality of treatment. This is similar to the study by Sargeran et al. [21] 2008 who had a survival rate of 84% at 24 months but in contrast to a study undertaken by Yeole et al. [22] Another factor for high survival rate could be buccal mucosa being the most frequent site of occurrence. This is similar to the findings of Chandu et al. [23] where patients with OSCC of buccal mucosa had the 5-year survival rate of 83.3%.
Conclusion
The clinical presentation and treatment outcome of OSCC patients with the habit of smokeless tobacco is presented. The increased survival rate in our patients could be due to surgery being the main treatment modality, followed by post-operative RT wherever indicated and buccal mucosa being the most frequent site.
OSCC has a diverse presentation due to social and economic factors. Hence, public health education and early diagnosis should be prioritized to improve long-term survival rates in oral cancer patients.
